Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HD18 for Advanced Hodgkin Lymphoma
NCT00515554Phase 3Completed
- Sponsor
- University of Cologne
- Start
- May 2008
- Primary completion
- Jul 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in Hodgkin lymphoma (HL), sponsored by University of Cologne. Started May 2008; status: completed.
02
Drugs
rituximab
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00515554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00515554.